Recruiting
Phase 2

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

Sponsor:

University of Colorado, Denver

Code:

NCT05379972

Conditions

Gastric Cancer

GastroEsophageal Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Olaparib

Stereotactic Body Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information